Found: 7
Select item for more details and to access through your institution.
A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, v. 8, n. 2, p. 1, doi. 10.1177/20552173221099186
- By:
- Publication type:
- Article
Tixagevimab and Cilgavimab (Evusheld™) Prophylaxis Prevents Breakthrough COVID-19 Infections in Immunosuppressed Population: 6-Month Prospective Study.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 350, doi. 10.3390/vaccines11020350
- By:
- Publication type:
- Article
COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 695, doi. 10.3390/vaccines10050695
- By:
- Publication type:
- Article
Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment.
- Published in:
- CNS Drugs, 2022, v. 36, n. 1, p. 45, doi. 10.1007/s40263-021-00887-w
- By:
- Publication type:
- Article
Cognitive function in severe progressive multiple sclerosis.
- Published in:
- Brain Communications, 2024, v. 6, n. 4, p. 1, doi. 10.1093/braincomms/fcae226
- By:
- Publication type:
- Article
Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives.
- Published in:
- Patient Related Outcome Measures, 2019, v. 10, p. 373, doi. 10.2147/PROM.S168095
- By:
- Publication type:
- Article
Post-Partum Clinical and Patient-Reported Outcome Changes in Mothers with Multiple Sclerosis: Findings from the NAPPREMS Study.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 7, p. 1159, doi. 10.3390/medicina60071159
- By:
- Publication type:
- Article